Participation of BRCA1 in the DNA repair response...via transcription

Cancer Biology and Therapy

Volumn 1, Issue 2, 2002, Pages 187-188

  Monteiro, Alvaro N A ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DDB2 PROTEIN, HUMAN; DNA BINDING PROTEIN;

ANIMAL; CELL CULTURE; DNA DAMAGE; DNA REPAIR; GENETIC TRANSCRIPTION; GENETICS; HUMAN; NOTE; PHYSIOLOGY; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; GENES, BRCA1; GENES, P53; HUMANS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS;

EID: 0036490136     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.66     Document Type: Note

References (22)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266:66-71. (Pubitemid 24345325)
2. Venkitaraman AR. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 2002; 108:171-82. (Pubitemid 34161138)
3. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 2000; 10:886-95. (Pubitemid 30647617)
4. Monteiro AN. BRCA1: exploring the links to transcription. Trends Biochem Sci 2000; 25:469-74.
5. Ouchi T, Monteiro AN, August A, Aaronson SA, Hanafusa H. BRCA1 regulates p53-dependent gene expression. Proc Natl Acad Sci USA 1998; 95:2302-6. (Pubitemid 28145936)
6. Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Zhang H, et al. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 1997; 389:187-90. (Pubitemid 27400601)
7. Ouchi T, Lee SW, Ouchi M, Aaronson SA, Horvath CM. Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes. Proc Natl Acad Sci USA 2000; 97:5208-13. (Pubitemid 30313697)
8. Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, et al. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 1999; 97:575-86. (Pubitemid 29256961)
9. MacLachlan TK, Somasundaram K, Sgagias M, Shifman Y, Muschel RJ, Cowan KH, et al. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J Biol Chem 2000; 275:2777-85. (Pubitemid 30082049)
10. Fornace AJ, Jr., Nebert DW, Hollander MC, Luethy JD, Papathanasiou M, Fargnoli J, et al. Mammalian genes coordinately regulated by growth arrest signals and DNA- damaging agents. Mol Cell Biol 1989; 9:4196-203. (Pubitemid 19239587)
11. Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, et al. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 1997; 90:425-35. (Pubitemid 27347233)
12. Tibbetts RS, Cortez D, Brumbaugh KM, Scully R, Livingston D, Elledge SJ, et al. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev 2000; 14:2989-3002.
13. Gatei M, Zhou BB, Hobson K, Scott S, Young D, Khanna KK. Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies. J Biol Chem 2001; 276:17276-80.
14. Takimoto R, MacLachlan TK, Dicker DT, Niitsu Y, Mori T, El Deiry WS. Cancer Biology and Therapy 2002; 1:177-186.
15. Chu G, Chang E. Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA. Science 1988; 242:564-7. (Pubitemid 18263195)
16. Tang JY, Hwang BJ, Ford JM, Hanawalt PC, Chu G. Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis. Mol Cell 2000; 5:737-44.
17. Ludwig T, Chapman DL, Papaioannou VE, Efstratiadis A. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev 1997; 11:1226-1241. (Pubitemid 27235356)
18. Hakem R, de la Pompa JL, Elia A, Potter J, Mak TW. Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation. Nat Genet 1997; 16:298-302.
19. Crook T, Crossland S, Crompton MR, Osin P, Gusterson BA. p53 mutations in BRCA1-associated familial breast cancer. Lancet 1997; 350:638-9. (Pubitemid 27367803)
20. Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T, et al. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 1999; 22:37-43. (Pubitemid 29214802)
21. Arizti P, Fang L, Park I, Yin Y, Solomon E, Ouchi T, et al. Tumor suppressor p53 is required to modulate BRCA1 expression. Mol Cell Biol 2000; 20:7450-7459.
22. MacLachlan TK, Dash BC, Dicker DT, El Deiry WS. Repression of BRCA1 through a feedback loop involving p53. J Biol Chem 2000; 275:31869-75.